VIVEbiotech takes part in two key cell & gene therapy events in Europe and Asia
The company participated simultaneously in the Cell & Gene Meeting on the Med in Rome and BIO KOREA in Seoul, engaging in global CGT discussions across two continents.
Over a three‑day period, VIVEbiotech took part in two major international cell and gene therapy (CGT) events held simultaneously in Europe and Asia, engaging with industry leaders, partners and stakeholders from the global CGT ecosystem.
In Europe, the company attended the Cell & Gene Meeting on the Med, organized by the Alliance for Regenerative Medicine and held in Rome from April 28 to 30. Patricio Massera, President and Board Member, and Jon Alberdi, CEO of VIVEbiotech, represented the company onsite, participating in meetings and discussions with decision‑makers and key players in the CGT field.
At the same time, VIVEbiotech was present in Asia as an exhibitor at BIO KOREA, held at COEX, Seoul. Natalia Elizalde, PhD, Chief Business Development Officer, and Víctor Polo, Business Development Manager, represented the company onsite, holding multiple meetings with biotech companies, partners and international stakeholders throughout the event.
Across both events, VIVEbiotech engaged in meaningful conversations around lentiviral vector manufacturing, collaboration opportunities and the future development of cell and gene therapies at a global scale. These exchanges allowed the company to share expertise, explore synergies and further connect with the international CGT community.
VIVEbiotech would like to thank everyone who connected with the team during these events and looks forward to continuing these conversations in future industry forums.